글로벌 뉴로모듈레이션 (신경 조절) 시장 2023-2027 L130: 이식형 뉴로모듈레이션 (신경 조절) 장치, 체외형 뉴로모듈레이션 (신경 조절) 장치

■ 영문 제목 : Global Neuromodulation Market 2023-2027

Technavio가 발행한 조사보고서이며, 코드는 IRTNTR40310-23 입니다.■ 상품코드 : IRTNTR40310-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 7월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (주문후 24시간내)
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의료
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1인 열람용)USD2,500 ⇒환산₩3,375,000견적의뢰/주문/질문
Enterprise License (기업 열람용)USD4,000 ⇒환산₩5,400,000견적의뢰/주문/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
글로벌 뉴로모듈레이션 (신경 조절) 시장 2023-2027
뉴로모듈레이션 (신경 조절) 시장은 2022년에서 2027년까지 5억 3,329만 달러로 성장하며, 예측 기간 동안 12.02%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 뉴로모듈레이션 (신경 조절) 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 그리고 약 25개 벤더에 대한 벤더 분석 등의 정보를 담고 있습니다.
현재 시장 시나리오, 최신 동향 및 촉진 요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 노인 인구의 증가, 의료에 대한 인식 개선 노력과 접근성 증가, 신경 질환의 유병률 증가에 의해 주도되고 있습니다.

Technavio사의 뉴로모듈레이션 (신경 조절) 시장은 다음과 같이 구분됩니다.

제품별
- 이식형 뉴로모듈레이션 (신경 조절)장치
- 체외형 뉴로모듈레이션 (신경 조절)장치

최종 용도별
- 병원
- 조혈모세포 이식
- 기타

지역별
- 북미
- 유럽
- 아시아
- 기타 지역(ROW)

이 연구는 향후 몇 년 동안 뉴로모듈레이션 (신경 조절) 시장의 성장을 촉진하는 주요 이유 중 하나로 신경학에 대한 자금 지원의 증가를 꼽고 있습니다. 또한, 신흥국에서의 의료관광 증가와 뉴로모듈레이션 (신경 조절)의 적용 확대도 시장의 큰 수요로 이어질 것으로 예상되고 있습니다.

본 보고서에서는 뉴로모듈레이션 (신경 조절) 시장과 관련하여 다음과 같은 분야를 다루고 있습니다.
- 뉴로모듈레이션 (신경 조절) 시장 규모
- 뉴로모듈레이션 (신경 조절) 시장 예측
- 뉴로모듈레이션 (신경 조절) 시장의 산업 분석

강력한 벤더 분석은 고객이 시장 지위를 향상시킬 수 있도록 설계되었으며, 이에 따라 본 보고서에서는 Abbott Laboratories, Axonics Inc., BioWave Ltd., Boston Scientific Corp., BrainsWay Ltd., Cognito Therapeutics, electroCore Inc., Evren Technologies Inc., LivaNova Plc, Medtronic Plc, NeuroMetrix Inc., NEURONETICS Inc., Nevro Corp., OMRON Corp., PathMaker Neurosystems Inc., Saluda Medical Pty Ltd., ShiraTronics, Theranica Bio Electronics Ltd., Thync Global Inc., 및 Ziv HealthCare Ltd. 등의 기업 정보를 수록하고 있습니다. 또한, 뉴로모듈레이션 (신경 조절) 시장 분석 보고서에는 시장 성장에 영향을 미치는 향후 동향과 과제에 대한 정보도 포함되어 있습니다. 이는 기업이 전략을 수립하고 다가오는 모든 성장 기회를 활용하는 데 도움이 될 것입니다.

이 연구는 업계 주요 참가자들의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서는 주요 벤더에 대한 분석과 함께 포괄적인 시장 및 벤더 현황을 제공합니다.

이 보고서는 이익, 가격, 경쟁, 프로모션 등 주요 매개변수를 분석하여 여러 출처의 데이터를 조사, 통합, 요약하는 방식으로 시장의 상세한 모습을 제시합니다. 또한, 주요 산업 영향력자를 식별하여 시장의 다양한 측면을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있는 1차 및 2차에 걸친 광범위한 조사 결과입니다. 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해 완전한 경쟁 환경과 정성적 및 정량적 조사를 통한 면밀한 공급업체 선정 방법 및 분석을 제공합니다.
■ 보고서 개요

1. 개요
2. 세계의 뉴로모듈레이션 (신경 조절) 시장 현황
3. 세계의 뉴로모듈레이션 (신경 조절) 시장 규모
4. 과거 시장 규모
5. 파이브 포스 분석
6. 제품별 시장 분석
7. 최종 용도별 시장 분석
8. 고객 현황
9. 지역별 분석
10. 추진 요인/과제/동향
11. 기업 현황
12. 기업 분석
13. 부록

■ 보고서 목차

1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global neuromodulation market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global neuromodulation market 2017 – 2021 ($ billion)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
o 4.3 End-user Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Implantable neuromodulation devices – Market size and forecast 2022-2027
o Exhibit 34: Chart on Implantable neuromodulation devices – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Implantable neuromodulation devices – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Implantable neuromodulation devices – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Implantable neuromodulation devices – Year-over-year growth 2022-2027 (%)
o 6.4 External neuromodulation devices – Market size and forecast 2022-2027
o Exhibit 38: Chart on External neuromodulation devices – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on External neuromodulation devices – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on External neuromodulation devices – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on External neuromodulation devices – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ billion)
o Exhibit 43: Data Table on Market opportunity by Product ($ billion)
7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 44: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 45: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 46: Chart on Comparison by End-user
o Exhibit 47: Data Table on Comparison by End-user
o 7.3 Hospitals – Market size and forecast 2022-2027
o Exhibit 48: Chart on Hospitals – Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Data Table on Hospitals – Market size and forecast 2022-2027 ($ billion)
o Exhibit 50: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
o 7.4 ASCs – Market size and forecast 2022-2027
o Exhibit 52: Chart on ASCs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Data Table on ASCs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 54: Chart on ASCs – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on ASCs – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 56: Chart on Others – Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on Others – Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 60: Market opportunity by End-user ($ billion)
o Exhibit 61: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 91: Chart on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Japan – Market size and forecast 2022-2027
o Exhibit 95: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 99: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 111: Abbott Laboratories – Overview
o Exhibit 112: Abbott Laboratories – Business segments
o Exhibit 113: Abbott Laboratories – Key news
o Exhibit 114: Abbott Laboratories – Key offerings
o Exhibit 115: Abbott Laboratories – Segment focus
o 12.4 Axonics Inc.
o Exhibit 116: Axonics Inc. – Overview
o Exhibit 117: Axonics Inc. – Business segments
o Exhibit 118: Axonics Inc. – Key offerings
o Exhibit 119: Axonics Inc. – Segment focus
o 12.5 Boston Scientific Corp.
o Exhibit 120: Boston Scientific Corp. – Overview
o Exhibit 121: Boston Scientific Corp. – Business segments
o Exhibit 122: Boston Scientific Corp. – Key news
o Exhibit 123: Boston Scientific Corp. – Key offerings
o Exhibit 124: Boston Scientific Corp. – Segment focus
o 12.6 BrainsWay Ltd.
o Exhibit 125: BrainsWay Ltd. – Overview
o Exhibit 126: BrainsWay Ltd. – Product / Service
o Exhibit 127: BrainsWay Ltd. – Key offerings
o 12.7 electroCore Inc.
o Exhibit 128: electroCore Inc. – Overview
o Exhibit 129: electroCore Inc. – Product / Service
o Exhibit 130: electroCore Inc. – Key offerings
o 12.8 LivaNova Plc
o Exhibit 131: LivaNova Plc – Overview
o Exhibit 132: LivaNova Plc – Business segments
o Exhibit 133: LivaNova Plc – Key offerings
o Exhibit 134: LivaNova Plc – Segment focus
o 12.9 Medtronic Plc
o Exhibit 135: Medtronic Plc – Overview
o Exhibit 136: Medtronic Plc – Business segments
o Exhibit 137: Medtronic Plc – Key news
o Exhibit 138: Medtronic Plc – Key offerings
o Exhibit 139: Medtronic Plc – Segment focus
o 12.10 NeuroMetrix Inc.
o Exhibit 140: NeuroMetrix Inc. – Overview
o Exhibit 141: NeuroMetrix Inc. – Product / Service
o Exhibit 142: NeuroMetrix Inc. – Key offerings
o 12.11 NEURONETICS Inc.
o Exhibit 143: NEURONETICS Inc. – Overview
o Exhibit 144: NEURONETICS Inc. – Product / Service
o Exhibit 145: NEURONETICS Inc. – Key offerings
o 12.12 Nevro Corp.
o Exhibit 146: Nevro Corp. – Overview
o Exhibit 147: Nevro Corp. – Product / Service
o Exhibit 148: Nevro Corp. – Key offerings
o 12.13 OMRON Corp.
o Exhibit 149: OMRON Corp. – Overview
o Exhibit 150: OMRON Corp. – Business segments
o Exhibit 151: OMRON Corp. – Key news
o Exhibit 152: OMRON Corp. – Key offerings
o Exhibit 153: OMRON Corp. – Segment focus
o 12.14 PathMaker Neurosystems Inc.
o Exhibit 154: PathMaker Neurosystems Inc. – Overview
o Exhibit 155: PathMaker Neurosystems Inc. – Product / Service
o Exhibit 156: PathMaker Neurosystems Inc. – Key offerings
o 12.15 Saluda Medical Pty Ltd.
o Exhibit 157: Saluda Medical Pty Ltd. – Overview
o Exhibit 158: Saluda Medical Pty Ltd. – Product / Service
o Exhibit 159: Saluda Medical Pty Ltd. – Key offerings
o 12.16 ShiraTronics
o Exhibit 160: ShiraTronics – Overview
o Exhibit 161: ShiraTronics – Product / Service
o Exhibit 162: ShiraTronics – Key offerings
o 12.17 Theranica Bio Electronics Ltd.
o Exhibit 163: Theranica Bio Electronics Ltd. – Overview
o Exhibit 164: Theranica Bio Electronics Ltd. – Product / Service
o Exhibit 165: Theranica Bio Electronics Ltd. – Key offerings
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 166: Inclusions checklist
o Exhibit 167: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 168: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 169: Research methodology
o Exhibit 170: Validation techniques employed for market sizing
o Exhibit 171: Information sources
o 13.5 List of abbreviations
o Exhibit 172: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global neuromodulation market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – End-user Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Implantable neuromodulation devices – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Implantable neuromodulation devices – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Implantable neuromodulation devices – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Implantable neuromodulation devices – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on External neuromodulation devices – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on External neuromodulation devices – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on External neuromodulation devices – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on External neuromodulation devices – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ billion)
Exhibits43: Data Table on Market opportunity by Product ($ billion)
Exhibits44: Chart on End-user – Market share 2022-2027 (%)
Exhibits45: Data Table on End-user – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by End-user
Exhibits47: Data Table on Comparison by End-user
Exhibits48: Chart on Hospitals – Market size and forecast 2022-2027 ($ billion)
Exhibits49: Data Table on Hospitals – Market size and forecast 2022-2027 ($ billion)
Exhibits50: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on ASCs – Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on ASCs – Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on ASCs – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on ASCs – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Others – Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Others – Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by End-user ($ billion)
Exhibits61: Data Table on Market opportunity by End-user ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Abbott Laboratories – Overview
Exhibits112: Abbott Laboratories – Business segments
Exhibits113: Abbott Laboratories – Key news
Exhibits114: Abbott Laboratories – Key offerings
Exhibits115: Abbott Laboratories – Segment focus
Exhibits116: Axonics Inc. – Overview
Exhibits117: Axonics Inc. – Business segments
Exhibits118: Axonics Inc. – Key offerings
Exhibits119: Axonics Inc. – Segment focus
Exhibits120: Boston Scientific Corp. – Overview
Exhibits121: Boston Scientific Corp. – Business segments
Exhibits122: Boston Scientific Corp. – Key news
Exhibits123: Boston Scientific Corp. – Key offerings
Exhibits124: Boston Scientific Corp. – Segment focus
Exhibits125: BrainsWay Ltd. – Overview
Exhibits126: BrainsWay Ltd. – Product / Service
Exhibits127: BrainsWay Ltd. – Key offerings
Exhibits128: electroCore Inc. – Overview
Exhibits129: electroCore Inc. – Product / Service
Exhibits130: electroCore Inc. – Key offerings
Exhibits131: LivaNova Plc – Overview
Exhibits132: LivaNova Plc – Business segments
Exhibits133: LivaNova Plc – Key offerings
Exhibits134: LivaNova Plc – Segment focus
Exhibits135: Medtronic Plc – Overview
Exhibits136: Medtronic Plc – Business segments
Exhibits137: Medtronic Plc – Key news
Exhibits138: Medtronic Plc – Key offerings
Exhibits139: Medtronic Plc – Segment focus
Exhibits140: NeuroMetrix Inc. – Overview
Exhibits141: NeuroMetrix Inc. – Product / Service
Exhibits142: NeuroMetrix Inc. – Key offerings
Exhibits143: NEURONETICS Inc. – Overview
Exhibits144: NEURONETICS Inc. – Product / Service
Exhibits145: NEURONETICS Inc. – Key offerings
Exhibits146: Nevro Corp. – Overview
Exhibits147: Nevro Corp. – Product / Service
Exhibits148: Nevro Corp. – Key offerings
Exhibits149: OMRON Corp. – Overview
Exhibits150: OMRON Corp. – Business segments
Exhibits151: OMRON Corp. – Key news
Exhibits152: OMRON Corp. – Key offerings
Exhibits153: OMRON Corp. – Segment focus
Exhibits154: PathMaker Neurosystems Inc. – Overview
Exhibits155: PathMaker Neurosystems Inc. – Product / Service
Exhibits156: PathMaker Neurosystems Inc. – Key offerings
Exhibits157: Saluda Medical Pty Ltd. – Overview
Exhibits158: Saluda Medical Pty Ltd. – Product / Service
Exhibits159: Saluda Medical Pty Ltd. – Key offerings
Exhibits160: ShiraTronics – Overview
Exhibits161: ShiraTronics – Product / Service
Exhibits162: ShiraTronics – Key offerings
Exhibits163: Theranica Bio Electronics Ltd. – Overview
Exhibits164: Theranica Bio Electronics Ltd. – Product / Service
Exhibits165: Theranica Bio Electronics Ltd. – Key offerings
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Validation techniques employed for market sizing
Exhibits171: Information sources
Exhibits172: List of abbreviations

※본 조사보고서 [글로벌 뉴로모듈레이션 (신경 조절) 시장 2023-2027 L130: 이식형 뉴로모듈레이션 (신경 조절) 장치, 체외형 뉴로모듈레이션 (신경 조절) 장치] (코드 : IRTNTR40310-23) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [글로벌 뉴로모듈레이션 (신경 조절) 시장 2023-2027 L130: 이식형 뉴로모듈레이션 (신경 조절) 장치, 체외형 뉴로모듈레이션 (신경 조절) 장치] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!